|
1
|
Finne P, Reunanen A, Stenman S, Groop PH
and Grönhagen-Riska C: Incidence of end-stage renal disease in
patients with type 1 diabetes. JAMA. 294:1782–1787. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Asahara T, Murohara T, Sullivan A, Silver
M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Singh J, Chaudhari BP and Kakkar P:
Baicalin and chrysin mixture imparts cyto-protection against
methylglyoxal induced cytotoxicity and diabetic tubular injury by
modulating RAGE, oxidative stress and inflammation. Environ Toxicol
Pharmacol. 50:67–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rashid K, Chowdhury S, Ghosh S and Sil PC:
Curcumin attenuates oxidative stress induced NFκB mediated
inflammation and endoplasmic reticulum dependent apoptosis of
splenocytes in diabetes. Biochem Pharmacol. 143:140–155. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El-Remessy AB, Franklin T, Ghaley N, Yang
J, Brands MW, Caldwell RB and Behzadian MA: Correction:
Diabetes-induced superoxide anion and breakdown of the
blood-retinal barrier: Role of the VEGF/uPAR pathway. PLoS One.
12:e01867492017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bassino E, Antoniotti S, Gasparri F and
Munaron L: Effects of flavonoid derivatives on human microvascular
endothelial cells. Nat Prod Res. 2:1–4. 2016.
|
|
7
|
Han H, Cao A, Wang L, Guo H, Zang Y, Li Z,
Zhang X and Peng W: Huangqi decoction ameliorates
streptozotocin-induced rat diabetic nephropathy through antioxidant
and regulation of the TGF-β/MAPK/PPAR-γ signaling. Cell Physiol
Biochem. 42:1934–1944. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sha J, Sui B, Su X, Meng Q and Zhang C:
Alteration of oxidative stress and inflammatory cytokines induces
apoptosis in diabetic nephropathy. Mol Med Rep. 16:7715–7723. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ross R: Atherosclerosis - an inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mogensen CE, Christensen CK and Vittinghus
E: The stages in diabetic renal disease. With emphasis on the stage
of incipient diabetic nephropathy. Diabetes. 32:64–78. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ishikawa F, Yasukawa M, Yoshida S,
Nakamura K, Nagatoshi Y, Kanemaru T, Shimoda K, Shimoda S, Miyamoto
T, Okamura J, et al: Human cord blood- and bone marrow-derived
CD34+ cells regenerate gastrointestinal epithelial cells. FASEB J.
18:1958–1960. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang KL, Chen CS, Hsu CW, Li MH, Chang H,
Tsai SH and Chu SJ: Therapeutic effects of baicalin on
lipopolysaccharide-induced acute lung injury in rats. Am J Chin
Med. 36:301–311. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li XX and Zhao RM: Observation of the
curative effect of liuwei dihuang pill on early diabetic
nephropathy. Med Innov Chin. 25:31–32. 2011.
|
|
14
|
Pan X, Huang CL and Lin XX: Protection
effect of baicalein on myocardial ischemia-reperfusion injury in
rats. J Gannan Med Univ. 28:493–495. 2008.
|
|
15
|
Cui XY, Zhang M and Shi L: Protective
effect of baicalin on hydrogen peroxide-induced oxidative damage to
primary cultured hippocampal neurons in neonatal rats. Chin J Clin
Pharmacol. 32:2081–2084. 2016.
|
|
16
|
Mollah ZU, Pai S, Moore C, O'Sullivan BJ,
Harrison MJ, Peng J, Phillips K, Prins JB, Cardinal J and Thomas R:
Abnormal NF-kappa B function characterizes human type 1 diabetes
dendritic cells and monocytes. J Immunol. 180:3166–3175. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu T, Zhang L, Joo D and Sun SC: NF-κB
signaling in inflammation. Signal Transduct Target Ther. 2(pii):
170232017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakagawa T, Sato W, Kosugi T and Johnson
RJ: Uncoupling of VEGF with endothelial NO as a potential mechanism
for abnormal angiogenesis in the diabetic nephropathy. J Diabetes
Res. 2013:1845392013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li XJ, Wang ZM, Guo YC and Min XZ:
Relationship between serum levels of VEGF, IL-6 and Cys-C with type
2 diabetic nephropathy. Lab Med Clin. 11:3207–3211. 2015.
|
|
20
|
Kim NH, Oh JH, Seo JA, Lee KW, Kim SG,
Choi KM, Baik SH, Choi DS, Kang YS, Han SY, et al: Vascular
endothelial growth factor (VEGF) and soluble VEGF receptor Flt-1 in
diabetic nephropathy. Kidney Int. 67:167–177. 2005. View Article : Google Scholar : PubMed/NCBI
|
